MENU

  • Home
  • Dit zijn wij
  • Aangenaam kennis te maken
  • Voor bedrijven en organisaties
  • Voor professionals
  • Regulatory Submissions
  • Medical Affairs
  • Research & Development
  • Training & Coaching
  • Outplacement
  • Zorg
  • The Perfect Match
  • Portfolio
  • Job Opportunities
  • Nieuws
  • Contact

Recent nieuws

  • Belangrijk: Verduidelijking met betrekking tot de Verklaring Geschiktheid Onderzoeksinstelling (VGO);
  • Science Policy 2020 – 2024: ‘Regulating with the knowledge of tomorrow’
  • Public Web Conference to Provide Progress Update on ICH E6 Guideline for Good Clinical Practice
+ 31575441001office@schmidtconsultancy.nl
logo
Please assign a menu to the primary menu location under Menus.
Please assign a menu to the primary menu location under Menus.
logo
Schmidt Consultancy
Prev
0
Studie starten in 2021? Houd rekening met veranderingen!
30 december 2020
Next
0
FD: investeringsgolf farmabedrijven in Nederland
11 februari 2021
30 december 2020 by Meta Horstman in Over COVID-19

News 22/12/2020

EMA will organise a second public meeting on 8 January 2021 to inform European citizens about the assessment, approval and roll-out of new COVID-19 vaccines.

Together with the EU medicines regulatory network, EMA has been working around the clock to bring much needed COVID-19 vaccines to EU citizens as quickly as possible, while keeping the same rigorous standards of approval as for all vaccines.

The first COVID-19 vaccine, Comirnaty, developed by BioNTech and Pfizer has been authorised in the EU on 21 December 2020. An application for a marketing authorisation for another COVID-19 vaccine, developed by Moderna, is currently ongoing and could be concluded at an extraordinary meeting of EMA’s human medicines committee (CHMP) on 6 January 2021.

The public meeting will be an opportunity to inform citizens about the approval and use of the new vaccines, to explain how the safety of the vaccines will be assured, and to provide information on the role of the European Commission and the national public health authorities on the roll-out of the vaccines. Participants will be also able to share their views, expectations and raise any concerns.

The meeting will be held online and will be open to all citizens. Those interested in participating and asking questions to the panellists should fill in this form no later than 31 December 2020. The meeting will be also broadcast live.

The PDF iconagenda of the event is available on EMA’s website.

0
Recommend
  • Facebook
  • Twitter
  • LinkedIN
Share
Tagged in

Recent comments

    Tags

    logo